2/21/2025 11:40 AM
Hims & Hers Health Inc (NYSE:HIMS) stock has had a roller coaster week. The shares gapped higher by 17.5% on Tuesday despite a downgrade, unironically, to "equal-weight" from "overweight" at Morgan St...
2/13/2025 12:36 PM
Weight-loss drugs have been popular over the past couple of years, and Hims & Hers Health Inc (NYSE:HIMS), Novo Nordisk A/S (NYSE:NVO), and Viking Therapeutics Inc (NASDAQ:VKTX) are among the most...
2/5/2025 10:58 AM
Pharmaceutical concern Novo Nordisk A/S (NYSE:NVO) is up 4.9% at $86.63 at last glance. The company posted strong fourth-quarter results and better-than-expected full-year revenue for 2024, as weigh...
1/24/2025 10:10 AM
Novo Nordisk A/S (NYSE:NVO) today announced positive early-stage trial results for its amycretin obesity drug. The treatment, which overweight and obese patients used once a week, resulted in 22% we...
1/8/2025 9:08 AM
U.S.-listed shares of Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) are up 3.5% premarket, following a bull note from UBS. The analyst in question upgraded NVO to "buy" from "neutral," citin...